We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

As Court Battle Rages, Pfizer's Celebrex Sales Soar

Law360 (July 13, 2007, 12:00 AM EDT) -- In its annual financial statement to the U.S. Securities and Exchange Commission, drug maker Pfizer Inc. warned that “continuing concern” about the safety of its anti-inflammatory drug Celebrex might limit the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.